Food for thought: formulating away the food effect - a PEARRL review
dc.contributor.author | O'Shea, Joseph P. | |
dc.contributor.author | Holm, René | |
dc.contributor.author | O'Driscoll, Caitríona M. | |
dc.contributor.author | Griffin, Brendan T. | |
dc.contributor.funder | Horizon 2020 | en |
dc.date.accessioned | 2018-11-13T14:44:02Z | |
dc.date.available | 2018-11-13T14:44:02Z | |
dc.date.issued | 2018-06-28 | |
dc.date.updated | 2018-11-13T14:34:20Z | |
dc.description.abstract | Objectives: Co‐ingestion of oral dosage forms with meals can cause substantial changes in bioavailability relative to the fasted state. Food‐mediated effects on bioavailability can have significant consequences in drug development, regulatory and clinical settings. To date, the primary focus of research has focused on the ability to mechanistically understand the causes and predict the occurrence of these effects. Key findings: The current review describes the mechanisms underpinning the occurrence of food effects, sheds new insights on the relative frequency for newly licensed medicines and describes the various methods by which they can be overcome. Analysis of oral medicines licensed by either the EMA or FDA since 2010 revealed that over 40% display significant food effects. Due to altered bioavailability, these medicines are often required to be dosed, rather restrictively, in either the fed or the fasted state, which can hinder clinical usefulness. Summary: There are clinical and commercial advantages to predicting the presence of food effects early in the drug development process, in order to mitigate this risk of variable food effect bioavailability. Formulation approaches aimed at reducing variable food‐dependent bioavailability, through the use of bio‐enabling formulations, are an essential tool in addressing this challenge and the latest state of the art in this field are summarised here. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | O'Shea, J. P., Holm, R., O'Driscoll, C. M. and Griffin, B. T. 'Food for thought: formulating away the food effect – a PEARRL review', Journal of Pharmacy and Pharmacology, 71(4), pp.510-535 doi: 10.1111/jphp.12957 | en |
dc.identifier.doi | 10.1111/jphp.12957 | |
dc.identifier.endpage | 535 | en |
dc.identifier.issn | 0022-3573 | |
dc.identifier.issued | 4 | en |
dc.identifier.journaltitle | Journal of Pharmacy and Pharmacology | en |
dc.identifier.startpage | 510 | en |
dc.identifier.uri | https://hdl.handle.net/10468/7108 | |
dc.identifier.volume | 71 | en |
dc.language.iso | en | en |
dc.publisher | Wiley | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/H2020::MSCA-ITN-ETN/674909/EU/Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines/PEARRL | en |
dc.relation.uri | https://onlinelibrary.wiley.com/doi/abs/10.1111/jphp.12957 | |
dc.rights | © 2018 Royal Pharmaceutical Society. This is the peer reviewed version of the following article: O'Shea, J. P., Holm, R., O'Driscoll, C. M. and Griffin, B. T. (2018), Food for thought: formulating away the food effect – a PEARRL review. J Pharm Pharmacol., which has been published in final form at https://doi.org/10.1111/jphp.12957. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. | en |
dc.subject | Bio-enabling formulations | en |
dc.subject | Food effect | en |
dc.subject | Food-drug interactions | en |
dc.subject | Formulation screening | en |
dc.subject | Gastrointestinal physiology | en |
dc.title | Food for thought: formulating away the food effect - a PEARRL review | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 4 of 4
Loading...
- Name:
- FEReview-JO'Shea_et_al_clean_pre_proof.pdf
- Size:
- 973.9 KB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted Version
Loading...
- Name:
- 5903_FEReview-JO'Shea_et_al_Response2305.pdf
- Size:
- 844.84 KB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted version
Loading...
- Name:
- FEReview-JO'Shea_et_al_clean_pre_proof.docx
- Size:
- 1.08 MB
- Format:
- Microsoft Word XML
- Description:
- Updated Version
Loading...
- Name:
- RE Proof of 12957 for JOURNAL OF PHARMACY AND PHARMACOLOGY ready for review.txt
- Size:
- 4.31 KB
- Format:
- Plain Text
- Description:
- E-mail communication
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: